Credit Suisse Group (CS)

US2254011081 - ADR

0.8858  +0.01 (+0.99%)

After market: 0.899 +0.01 (+1.49%)

Fundamental Rating

1

CS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 210 industry peers in the Capital Markets industry. Both the profitability and financial health of CS have multiple concerns. CS does not seem to be growing, but still is valued expensively.



2

1. Profitability

1.1 Basic Checks

CS had negative earnings in the past year.
The reported net income has been mixed in the past 5 years: CS reported negative net income in multiple years.
In multiple years CS reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 1.00%, CS is in line with its industry, outperforming 48.02% of the companies in the same industry.
CS's Return On Equity of 10.01% is fine compared to the rest of the industry. CS outperforms 69.31% of its industry peers.
Industry RankSector Rank
ROA 1%
ROE 10.01%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CS has a Profit Margin of 18.68%. This is in the better half of the industry: CS outperforms 64.85% of its industry peers.
CS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 18.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CS has more shares outstanding than it did 1 year ago.
CS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CS is higher compared to a year ago.

2.2 Solvency

CS has a Debt/Equity ratio of 2.80. This is a high value indicating a heavy dependency on external financing.
CS has a worse Debt to Equity ratio (2.80) than 84.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

3

3. Growth

3.1 Past

The earnings per share for CS have decreased strongly by -702.95% in the last year.
The Revenue has grown by 48.34% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.52% on average over the past years.
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-576.1%
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y-6.52%
Revenue growth Q2Q318.56%

3.2 Future

CS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.46% yearly.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y82.2%
EPS Next 2Y39.87%
EPS Next 3Y27.69%
EPS Next 5Y16.46%
Revenue Next Year-4.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y0.61%
Revenue Next 5Y2.57%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

CS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CS's earnings are expected to grow with 27.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.87%
EPS Next 3Y27.69%

0

5. Dividend

5.1 Amount

No dividends for CS!.
Industry RankSector Rank
Dividend Yield N/A

Credit Suisse Group

NYSE:CS (6/9/2023, 7:04:01 PM)

After market: 0.899 +0.01 (+1.49%)

0.8858

+0.01 (+0.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.50B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1%
ROE 10.01%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 18.68%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y82.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y